Lantheus Holdings (LNTH) Shares Outstanding (Weighted Average) (2013 - 2026)

Lantheus Holdings (LNTH) reported Shares Outstanding (Weighted Average) of $64.7 million for Q1 2026, down 5.74% year-over-year from $68.7 million in Q1 2025, and down 4.08% quarter-over-quarter from $67.5 million in Q4 2025.

Lantheus Holdings (LNTH) Shares Outstanding (Weighted Average) (2013 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 14 years of Shares Outstanding (Weighted Average) data on file, last reported at $64.7 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $64.7 million, down 5.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $64.7 million (down 5.74% YoY), and the FY2025 annual result was $67.5 million, down 2.47% from the prior year.
  • Shares Outstanding (Weighted Average) slipped to $64.7 million in Q1 2026 per LNTH's latest filing, from $67.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $69.4 million in Q2 2024 and troughed at $64.7 million in Q1 2026.
  • A 5-year average of $68.2 million and a median of $68.4 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) climbed 2.0% in 2022, then fell 5.74% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $68.5 million in 2022, then slipped by 0.32% to $68.3 million in 2023, then climbed by 1.37% to $69.2 million in 2024, then slipped by 2.47% to $67.5 million in 2025, then declined by 4.08% to $64.7 million in 2026.
  • Business Quant data shows LNTH's Shares Outstanding (Weighted Average) at $64.7 million in Q1 2026, $67.5 million in Q4 2025, and $67.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 88.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 64.74 Mn
Dec 31, 2025 67.49 Mn
Sep 30, 2025 67.23 Mn
Jun 30, 2025 68.52 Mn
Mar 31, 2025 68.68 Mn
Dec 31, 2024 69.20 Mn
Sep 30, 2024 69.19 Mn
Jun 30, 2024 69.36 Mn
Mar 31, 2024 68.76 Mn
Dec 31, 2023 68.27 Mn
Sep 30, 2023 68.44 Mn
Jun 30, 2023 68.37 Mn
Mar 31, 2023 67.75 Mn
Dec 31, 2022 68.49 Mn
Sep 30, 2022 68.76 Mn
Jun 30, 2022 68.34 Mn
Mar 31, 2022 68.01 Mn
Dec 31, 2021 67.49 Mn
Sep 30, 2021 67.41 Mn
Jun 30, 2021 67.30 Mn